Top

Published in:

Open Access 01-12-2019 | Multiple Sclerosis | Research

Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis

Authors: Maria L. Elkjaer, Tobias Frisch, Richard Reynolds, Tim Kacprowski, Mark Burton, Torben A. Kruse, Mads Thomassen, Jan Baumbach, Zsolt Illes

Published in: Acta Neuropathologica Communications | Issue 1/2019

Abstract

To identify pathogenetic markers and potential drivers of different lesion types in the white matter (WM) of patients with progressive multiple sclerosis (PMS), we sequenced RNA from 73 different WM areas. Compared to 25 WM controls, 6713 out of 18,609 genes were significantly differentially expressed in MS tissues (FDR < 0.05). A computational systems medicine analysis was performed to describe the MS lesion endophenotypes. The cellular source of specific molecules was examined by RNAscope, immunohistochemistry, and immunofluorescence. To examine common lesion specific mechanisms, we performed de novo network enrichment based on shared differentially expressed genes (DEGs), and found TGFβ-R2 as a central hub. RNAscope revealed astrocytes as the cellular source of TGFβ-R2 in remyelinating lesions. Since lesion-specific unique DEGs were more common than shared signatures, we examined lesion-specific pathways and de novo networks enriched with unique DEGs. Such network analysis indicated classic inflammatory responses in active lesions; catabolic and heat shock protein responses in inactive lesions; neuronal/axonal specific processes in chronic active lesions. In remyelinating lesions, de novo analyses identified axonal transport responses and adaptive immune markers, which was also supported by the most heterogeneous immunoglobulin gene expression. The signature of the normal-appearing white matter (NAWM) was more similar to control WM than to lesions: only 465 DEGs differentiated NAWM from controls, and 16 were unique. The upregulated marker CD26/DPP4 was expressed by microglia in the NAWM but by mononuclear cells in active lesions, which may indicate a special subset of microglia before the lesion develops, but also emphasizes that omics related to MS lesions should be interpreted in the context of different lesions types. While chronic active lesions were the most distinct from control WM based on the highest number of unique DEGs (n = 2213), remyelinating lesions had the highest gene expression levels, and the most different molecular map from chronic active lesions. This may suggest that these two lesion types represent two ends of the spectrum of lesion evolution in PMS. The profound changes in chronic active lesions, the predominance of synaptic/neural/axonal signatures coupled with minor inflammation may indicate end-stage irreversible molecular events responsible for this less treatable phase.

Available only for authorised users

Alcaraz N, Kücük H, Weile J, Wipat A, Baumbach J (2011) KeyPathwayMiner: detecting case-specific biological pathways using expression data. Internet Math 7:299–313. https://doi.org/10.1080/15427951.2011.604548 CrossRef

Alcaraz N, Pauling J, Batra R, Barbosa E, Junge A, Christensen AGL, Azevedo V, Ditzel HJ, Baumbach J (2014) KeyPathwayMiner 4.0: condition-specific pathway analysis by combining multiple omics studies and networks with Cytoscape. BMC Syst Biol 8:99. https://doi.org/10.1186/s12918-014-0099-x CrossRefPubMedPubMedCentral

Alcina A, Vandenbroeck K, Otaegui D, Saiz A, Gonzalez JR, Fernandez O, Cavanillas ML, Cénit MC, Arroyo R, Alloza I, García-Barcina M, Antigüedad A, Leyva L, Izquierdo G, Lucas M, Fedetz M, Pinto-Medel MJ, Olascoaga J, Blanco Y, Comabella M, Montalban X, Urcelay E, Matesanz F (2010) The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun 11:439–445. https://doi.org/10.1038/gene.2010.30 CrossRefPubMed

Anders S, Pyl PT, Huber W (2015) HTSeq-A Python framework to work with high-throughput sequencing data. Bioinformatics 31:166–169. https://doi.org/10.1093/bioinformatics/btu638 CrossRefPubMed

Bando Y, Hagiwara Y, Suzuki Y, Yoshida K, Aburakawa Y, Kimura T, Murakami C, Ono M, Tanaka T, Jiang Y-P, Mitrovi B, Bochimoto H, Yahara O, Yoshida S (2018) Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis. Glia 66:359–378. https://doi.org/10.1002/glia.23249 CrossRefPubMed

Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. https://doi.org/10.1093/bioinformatics/btu170 CrossRefPubMedPubMedCentral

Boyd A, Zhang H, Williams A (2013) Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol 125:841–859. https://doi.org/10.1007/s00401-013-1112-y CrossRefPubMedPubMedCentral

Busso N, Wagtmann N, Herling C, Chobaz-Péclat V, Bischof-Delaloye A, So A, Grouzmann E (2005) Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 166:433–442. https://doi.org/10.1016/S0002-9440(10)62266-3 CrossRefPubMedPubMedCentral

Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O, Lassmann H, Turnbull DM, Mahad DJ (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69:481–492. https://doi.org/10.1002/ana.22109 CrossRefPubMed

10.

Clifford MA, Athar W, Leonard CE, Russo A, Sampognaro PJ, Van der Goes M-S, Burton DA, Zhao X, Lalchandani RR, Sahin M, Vicini S, Donoghue MJ (2014) EphA7 signaling guides cortical dendritic development and spine maturation. Proc Natl Acad Sci 111:4994–4999. https://doi.org/10.1073/pnas.1323793111 CrossRefPubMedPubMedCentral

11.

Cubillos-Rojas M, Schneider T, Hadjebi O, Pedrazza L, de Oliveira JR, Langa F, Guénet J-L, Duran J, de Anta JM, Alcántara S, Ruiz R, Pérez-Villegas EM, Aguilar-Montilla FJ, Carrión ÁM, Armengol JA, Baple E, Crosby AH, Bartrons R, Ventura F, Rosa JL (2016) The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination. Oncotarget 7:56083–56106. https://doi.org/10.18632/oncotarget.11270 CrossRefPubMedPubMedCentral

12.

De Feo D, Merlini A, Brambilla E, Ottoboni L, Laterza C, Menon R, Srinivasan S, Farina C, Garcia Manteiga JM, Butti E, Bacigaluppi M, Comi G, Greter M, Martino G (2017) Neural precursor cell-secreted TGF-β2 redirects inflammatory monocyte-derived cells in CNS autoimmunity. J Clin Invest 127:3937–3953. https://doi.org/10.1172/JCI92387 CrossRefPubMedPubMedCentral

13.

De Groot CJ, Montagne L, Barten AD, Sminia P, Van Der Valk P (1999) Expression of transforming growth factor (TGF)-beta1, −beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. J Neuropathol Exp Neurol 58:174–187CrossRefPubMed

14.

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21. https://doi.org/10.1093/bioinformatics/bts635 CrossRefPubMed

15.

Dobolyi A, Vincze C, Pál G, Lovas G (2012) The Neuroprotective functions of transforming growth factor Beta proteins. Int J Mol Sci 13:8219–8258. https://doi.org/10.3390/ijms13078219 CrossRefPubMedPubMedCentral

16.

Dutta R, Trapp BD (2014) Relapsing and progressive forms of multiple sclerosis: insights from pathology. Curr Opin Neurol 27:271–278. https://doi.org/10.1097/WCO.0000000000000094 CrossRefPubMedPubMedCentral

17.

Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10:48. https://doi.org/10.1186/1471-2105-10-48 CrossRefPubMedPubMedCentral

18.

Elbaz EM, Senousy MA, El-Tanbouly DM, Sayed RH (2018) Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation. Toxicol Appl Pharmacol 352:153–161. https://doi.org/10.1016/j.taap.2018.05.035 CrossRefPubMed

19.

Elkjaer ML, Frisch T, Reynolds R, Kacprowski T, Burton M, Kruse TA, Thomassen M, Baumbach J, Illes Z (2019) RETRACTED ARTICLE: unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis. Acta Neuropathol Commun 7:58. https://doi.org/10.1186/s40478-019-0709-3 CrossRefPubMedPubMedCentral

20.

Elkjaer ML, Frisch T, Reynolds R, Kacprowski T, Burton M, Kruse TA, Thomassen M, Baumbach J, Illes Z (2019) Retraction note: unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis. Acta Neuropathol Commun 7:136. https://doi.org/10.1186/s40478-019-0790-7 CrossRefPubMedPubMedCentral

21.

Ercan E, Han JM, Di Nardo A, Winden K, Han M-J, Hoyo L, Saffari A, Leask A, Geschwind DH, Sahin M (2017) Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex. J Exp Med 214:681–697. https://doi.org/10.1084/jem.20160446 CrossRefPubMedPubMedCentral

22.

Felts PA, Woolston A-M, Fernando HB, Asquith S, Gregson NA, Mizzi OJ, Smith KJ (2005) Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 128:1649–1666. https://doi.org/10.1093/brain/awh516 CrossRefPubMed

23.

Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120(Pt 3):393–399CrossRefPubMed

24.

Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132:1175–1189. https://doi.org/10.1093/brain/awp070 CrossRefPubMedPubMedCentral

25.

Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti CF (2015) Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol 78:710–721. https://doi.org/10.1002/ana.24497 CrossRefPubMedPubMedCentral

26.

Füvesi J, Hanrieder J, Bencsik K, Rajda C, Kovács SK, Kaizer L, Beniczky S, Vécsei L, Bergquist J (2012) Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis. Int J Mol Sci 13:7676–7693. https://doi.org/10.3390/ijms13067676 CrossRefPubMedPubMedCentral

27.

Goris A, Williams-Gray CH, Foltynie T, Brown J, Maranian M, Walton A, Compston DAS, Barker RA, Sawcer SJ (2007) Investigation of TGFB2 as a candidate gene in multiple sclerosis and Parkinson’s disease. J Neurol 254:846–848. https://doi.org/10.1007/s00415-006-0414-6 CrossRefPubMed

28.

Habermacher C, Angulo MC, Benamer N (2019) Glutamate versus GABA in neuron–oligodendroglia communication. Glia 67:2092–2106. https://doi.org/10.1002/glia.23618 CrossRefPubMed

29.

Haider L, Zrzavy T, Hametner S, Höftberger R, Bagnato F, Grabner G, Trattnig S, Pfeifenbring S, Brück W, Lassmann H (2016) The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain. Brain 139:awv398. https://doi.org/10.1093/brain/awv398 CrossRef

30.

Hautbergue GM, Castelli LM, Ferraiuolo L, Sanchez-Martinez A, Cooper-Knock J, Higginbottom A, Lin Y-H, Bauer CS, Dodd JE, Myszczynska MA, Alam SM, Garneret P, Chandran JS, Karyka E, Stopford MJ, Smith EF, Kirby J, Meyer K, Kaspar BK, Isaacs AM, El-Khamisy SF, De Vos KJ, Ning K, Azzouz M, Whitworth AJ, Shaw PJ (2017) SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits. Nat Commun 8:16063. https://doi.org/10.1038/ncomms16063 CrossRefPubMedPubMedCentral

31.

Hemmer B, Kerschensteiner M, Korn T (2015) Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol 14:406–419. https://doi.org/10.1016/S1474-4422(14)70305-9 CrossRefPubMed

32.

Hiremath MM, Chen VS, Suzuki K, Ting JPY, Matsushima GK (2008) MHC class II exacerbates demyelination in vivo independently of T cells. J Neuroimmunol 203:23–32. https://doi.org/10.1016/j.jneuroim.2008.06.034 CrossRefPubMedPubMedCentral

33.

Hoffjan S, Okur A, Epplen JT, Wieczorek S, Chan A, Akkad DA (2015) Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort. Int J Immunogenet 42:106–110. https://doi.org/10.1111/iji.12183 CrossRefPubMed

34.

Høglund RA, Lossius A, Johansen JN, Homan J, Benth JŠ, Robins H, Bogen B, Bremel RD, Holmøy T (2017) In Silico prediction analysis of Idiotope-driven T-B cell collaboration in multiple sclerosis. Front Immunol 8:1255. https://doi.org/10.3389/fimmu.2017.01255 CrossRefPubMedPubMedCentral

35.

Hu M-M, Shu H-B (2017) Multifaceted roles of TRIM38 in innate immune and inflammatory responses. Cell Mol Immunol 14:331–338. https://doi.org/10.1038/cmi.2016.66 CrossRefPubMedPubMedCentral

36.

Huynh JL, Garg P, Thin TH, Yoo S, Dutta R, Trapp BD, Haroutunian V, Zhu J, Donovan MJ, Sharp AJ, Casaccia P (2013) Epigenome-wide differences in pathology-free regions of multiple sclerosis–affected brains. Nat Neurosci 17:121–130. https://doi.org/10.1038/nn.3588 CrossRefPubMedPubMedCentral

37.

Huynh JL, Garg P, Thin TH, Yoo S, Dutta R, Trapp BD, Haroutunian V, Zhu J, Donovan MJ, Sharp AJ, Casaccia P (2014) Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains. Nat Neurosci 17:121–130. https://doi.org/10.1038/nn.3588 CrossRefPubMed

38.

Iparraguirre L, Muñoz-Culla M, Prada-Luengo I, Castillo-Triviño T, Olascoaga J, Otaegui D (2017) Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis. Hum Mol Genet 26:3564–3572. https://doi.org/10.1093/hmg/ddx243 CrossRefPubMed

39.

Jäkel S, Agirre E, Mendanha Falcão A, van Bruggen D, Lee KW, Knuesel I, Malhotra D, Ffrench-Constant C, Williams A, Castelo-Branco G (2019) Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566:543–547. https://doi.org/10.1038/s41586-019-0903-2 CrossRefPubMedPubMedCentral

40.

Johansen FE, Braathen R, Brandtzaeg P (2000) Role of J chain in secretory immunoglobulin formation. Scand J Immunol 52:240–248. https://doi.org/10.1046/j.1365-3083.2000.00790.x CrossRefPubMed

41.

Johansen JN, Vartdal F, Desmarais C, Tutturen AEVV, de Souza GA, Lossius A, Holmøy T (2015) Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome. Clin Immunol 160:211–225. https://doi.org/10.1016/j.clim.2015.06.001 CrossRefPubMed

42.

Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D (2002) The human genome browser at UCSC. Genome Res 12:996–1006. https://doi.org/10.1101/gr.229102 Article published online before print in may 2002CrossRefPubMedPubMedCentral

43.

Kim JY, Shen S, Dietz K, He Y, Howell O, Reynolds R, Casaccia P (2010) HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci 13:180–189. https://doi.org/10.1038/nn.2471 CrossRefPubMed

44.

Kotlyar M, Pastrello C, Sheahan N, Jurisica I (2016) Integrated interactions database: tissue-specific view of the human and model organism interactomes. Nucleic Acids Res 44:D536–D541. https://doi.org/10.1093/nar/gkv1115 CrossRefPubMed

45.

Kruer MC, Paisán-Ruiz C, Boddaert N, Yoon MY, Hama H, Gregory A, Malandrini A, Woltjer RL, Munnich A, Gobin S, Polster BJ, Palmeri S, Edvardson S, Hardy J, Houlden H, Hayflick SJ (2010) Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 68:611–618. https://doi.org/10.1002/ana.22122 CrossRefPubMedPubMedCentral

46.

Kuhlmann T, Lassmann H, Brück W (2008) Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Acta Neuropathol 115:275–287. https://doi.org/10.1007/s00401-007-0320-8 CrossRefPubMedPubMedCentral

47.

Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ (1991) Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A 88:2918–2921CrossRefPubMedPubMedCentral

48.

Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705–2712. https://doi.org/10.1093/brain/awh641 CrossRefPubMed

49.

Lassmann H (2014) Multiple sclerosis: lessons from molecular neuropathology. Exp Neurol 262(Pt A):2–7. https://doi.org/10.1016/j.expneurol.2013.12.003 CrossRefPubMed

50.

Lim YS, Tang BL (2013) The Evi5 family in cellular physiology and pathology. FEBS Lett 587:1703–1710. https://doi.org/10.1016/j.febslet.2013.04.036 CrossRefPubMed

51.

Lin R, Taylor BV, Simpson S, Charlesworth J, Ponsonby A-L, Pittas F, Dwyer T, van der Mei IAF (2014) Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis. J Neurol Neurosurg Psychiatry 85:399–404. https://doi.org/10.1136/jnnp-2013-305245 CrossRefPubMed

52.

Lipson KE, Wong C, Teng Y, Spong S (2012) CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair 5:S24. https://doi.org/10.1186/1755-1536-5-S1-S24 CrossRefPubMedPubMedCentral

53.

Liu Y, Hu H, Wang K, Zhang C, Wang Y, Yao K, Yang P, Han L, Kang C, Zhang W, Jiang T (2014) Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas. Oncotarget 5:12593–12606. https://doi.org/10.18632/oncotarget.2518 CrossRefPubMedPubMedCentral

54.

Lovato L, Willis SN, Rodig SJ, Caron T, Almendinger SE, Howell OW, Reynolds R, O’Connor KC, Hafler DA, O’Connor KC, Hafler DA (2011) Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain 134:534–541. https://doi.org/10.1093/brain/awq350 CrossRefPubMedPubMedCentral

55.

Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122:2279–2295. https://doi.org/10.1093/brain/122.12.2279 CrossRefPubMed

56.

Luchetti S, Fransen NL, van Eden CG, Ramaglia V, Mason M, Huitinga I (2018) Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis. Acta Neuropathol 135:511–528. https://doi.org/10.1007/s00401-018-1818-y CrossRefPubMedPubMedCentral

57.

Luo J, Ho PP, Buckwalter MS, Hsu T, Lee LY, Zhang H, Kim D-K, Kim S-J, Gambhir SS, Steinman L, Wyss-Coray T (2007) Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. J Clin Invest 117:3306–3315. https://doi.org/10.1172/JCI31763 CrossRefPubMedPubMedCentral

58.

Machado-Santos J, Saji E, Tröscher AR, Paunovic M, Liblau R, Gabriely G, Bien CG, Bauer J, Lassmann H (2018) The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain 141:2066–2082. https://doi.org/10.1093/brain/awy151 CrossRefPubMedPubMedCentral

59.

Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, Aloisi F, Reynolds R (2010) A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 68:477–493. https://doi.org/10.1002/ana.22230 CrossRefPubMed

60.

Mahad D, Lassmann H, Turnbull D (2008) Review: mitochondria and disease progression in multiple sclerosis. Neuropathol Appl Neurobiol 34:577–589. https://doi.org/10.1111/j.1365-2990.2008.00987.x CrossRefPubMedPubMedCentral

61.

Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 14:183–193. https://doi.org/10.1016/S1474-4422(14)70256-X CrossRefPubMed

62.

Makioka K, Yamazaki T, Takatama M, Ikeda M, Okamoto K (2014) Immunolocalization of Smurf1 in Hirano bodies. J Neurol Sci 336:24–28. https://doi.org/10.1016/j.jns.2013.09.028 CrossRefPubMed

63.

McClintick JN, Xuei X, Tischfield JA, Goate A, Foroud T, Wetherill L, Ehringer MA, Edenberg HJ (2013) Stress-response pathways are altered in the hippocampus of chronic alcoholics. Alcohol 47:505–515. https://doi.org/10.1016/j.alcohol.2013.07.002 CrossRefPubMed

64.

Nataf S, Barritault M, Pays L (2017) A unique TGFB1-driven genomic program links Astrocytosis, low-grade inflammation and partial demyelination in spinal cord Periplaques from progressive multiple sclerosis patients. Int J Mol Sci 18:2097. https://doi.org/10.3390/ijms18102097 CrossRefPubMedCentral

65.

Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple Sclerosis. N Engl J Med 343:938–952. https://doi.org/10.1056/NEJM200009283431307 CrossRefPubMed

66.

Obermeier B, Mentele R, Malotka J, Kellermann J, Kümpfel T, Wekerle H, Lottspeich F, Hohlfeld R, Dornmair K (2008) Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 14:688–693. https://doi.org/10.1038/nm1714 CrossRefPubMed

67.

Pathan M, Keerthikumar S, Ang C-S, Gangoda L, Quek CYJ, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim A, Bacic A, Hill AF, Stroud DA, Ryan MT, Agbinya JI, Mariadason JM, Burgess AW, Mathivanan S (2015) FunRich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics 15:2597–2601. https://doi.org/10.1002/pmic.201400515 CrossRefPubMed

68.

Preller V, Gerber A, Wrenger S, Togni M, Marguet D, Tadje J, Lendeckel U, Röcken C, Faust J, Neubert K, Schraven B, Martin R, Ansorge S, Brocke S, Reinhold D (2007) TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26. J Immunol 178:4632–4640. https://doi.org/10.4049/jimmunol.178.7.4632 CrossRefPubMed

69.

Prineas JW, Kwon EE, Cho E-S, Sharer LR, Barnett MH, Oleszak EL, Hoffman B, Morgan BP (2001) Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol 50:646–657. https://doi.org/10.1002/ana.1255 CrossRefPubMed

70.

Ragnedda G, Disanto G, Giovannoni G, Ebers GC, Sotgiu S, Ramagopalan SV (2012) Protein-protein interaction analysis highlights additional loci of interest for multiple sclerosis. PLoS One 7:e46730. https://doi.org/10.1371/journal.pone.0046730 CrossRefPubMedPubMedCentral

71.

Remington LT, Babcock AA, Zehntner SP, Owens T (2007) Microglial recruitment, activation, and proliferation in response to primary demyelination. Am J Pathol 170:1713–1724. https://doi.org/10.2353/ajpath.2007.060783 CrossRefPubMedPubMedCentral

72.

Reynolds R, Roncaroli F, Nicholas R, Radotra B, Gveric D, Howell O Djordje @bullet, @bullet G, Howell O(2011) The neuropathological basis of clinical progression in multiple sclerosis. Acta Neuropathol 122:155–170. https://doi.org/10.1007/s00401-011-0840-0 CrossRefPubMed

73.

Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139–140. https://doi.org/10.1093/bioinformatics/btp616 CrossRefPubMed

74.

Schirmer L, Velmeshev D, Holmqvist S, Kaufmann M, Werneburg S, Jung D, Vistnes S, Stockley JH, Young A, Steindel M, Tung B, Goyal N, Bhaduri A, Mayer S, Engler JB, Bayraktar OA, Franklin RJM, Haeussler M, Reynolds R, Schafer DP, Friese MA, Shiow LR, Kriegstein AR, Rowitch DH (2019) Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573:75–82. https://doi.org/10.1038/s41586-019-1404-z CrossRefPubMedPubMedCentral

75.

Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med PubMed – NCBI. http://www.ncbi.nlm.nih.gov/pubmed/17984305. Accessed 14 Jan 2016

76.

Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F (2004) Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14:164–174. https://doi.org/10.1111/j.1750-3639.2004.tb00049.x CrossRefPubMed

77.

Shen P, Fillatreau S (2015) Antibody-independent functions of B cells: a focus on cytokines. Nat Rev Immunol 15:441–451. https://doi.org/10.1038/nri3857 CrossRefPubMed

78.

Sironi M, Guerini FR, Agliardi C, Biasin M, Cagliani R, Fumagalli M, Caputo D, Cassinotti A, Ardizzone S, Zanzottera M, Bolognesi E, Riva S, Kanari Y, Miyazawa M, Clerici M (2011) An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseases. Mol Biol Evol 28:3319–3329. https://doi.org/10.1093/molbev/msr164 CrossRefPubMed

79.

Squires KE, Gerber KJ, Pare J-F, Branch MR, Smith Y, Hepler JR (2018) Regulator of G protein signaling 14 (RGS14) is expressed pre- and postsynaptically in neurons of hippocampus, basal ganglia, and amygdala of monkey and human brain. Brain Struct Funct 223:233–253. https://doi.org/10.1007/s00429-017-1487-y CrossRefPubMed

80.

Steinbrecher A, Reinhold D, Quigley L, Gado A, Tresser N, Izikson L, Born I, Faust J, Neubert K, Martin R, Ansorge S, Brocke S (2001) Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. J Immunol 166:2041–2048CrossRefPubMed

81.

Stern JNH, Yaari G, Vander Heiden JA, Church G, Donahue WF, Hintzen RQ, Huttner AJ, Laman JD, Nagra RM, Nylander A, Pitt D, Ramanan S, Siddiqui BA, Vigneault F, Kleinstein SH, Hafler DA, O’connor KC, Vander HJA, Church G, Donahue WF, Hintzen RQ, Huttner AJ, Laman JD, Nagra RM, Nylander A, Pitt D, Ramanan S, Siddiqui BA, Vigneault F, Kleinstein SH, Hafler DA, O’connor KC, Vander Heiden JA, Church G, Donahue WF, Hintzen RQ, Huttner AJ, Laman JD, Nagra RM, Nylander A, Pitt D, Ramanan S, Siddiqui BA, Vigneault F, Kleinstein SH, Hafler DA, O’connor KC (2014) B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes. Sci Transl Med 6:248ra107. https://doi.org/10.1126/scitranslmed.3008879 CrossRefPubMedPubMedCentral

82.

Tajiri N, De La Peña I, Acosta SA, Kaneko Y, Tamir S, Landesman Y, Carlson R, Shacham S, Borlongan CV (2016) A nuclear attack on traumatic brain injury: sequestration of cell death in the nucleus. CNS Neurosci Ther 22:306–315. https://doi.org/10.1111/cns.12501 CrossRefPubMedPubMedCentral

83.

Torkildsen Ø, Stansberg C, Angelskår SM, Kooi E-J, Geurts JJG, van der Valk P, Myhr K-M, Steen VM, Bø L (2010) Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol 20:720–729. https://doi.org/10.1111/j.1750-3639.2009.00343.x CrossRefPubMed

84.

Tuck E, Cavalli V (2010) Roles of membrane trafficking in nerve repair and regeneration. Commun Integr Biol 3:209–214. https://doi.org/10.4161/cib.3.3.11555 CrossRefPubMedPubMedCentral

85.

van der Poel M, Ulas T, Mizee MR, Hsiao C-C, Miedema SSM, Adelia SKG, Helder B, Tas SW, Schultze JL, Hamann J, Huitinga I (2019) Transcriptional profiling of human microglia reveals grey–white matter heterogeneity and multiple sclerosis-associated changes. Nat Commun 10:1139. https://doi.org/10.1038/s41467-019-08976-7 CrossRefPubMedPubMedCentral

86.

Wang J, Vasaikar S, Shi Z, Greer M, Zhang B (2017) WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res 45:W130–W137. https://doi.org/10.1093/nar/gkx356 CrossRefPubMedPubMedCentral

87.

Wang R, Wang H, Carrera I, Xu S, Lakshmana MK (2015) COPS5 protein overexpression increases amyloid plaque burden, decreases Spinophilin-immunoreactive Puncta, and exacerbates learning and memory deficits in the mouse brain. J Biol Chem 290:9299–9309. https://doi.org/10.1074/jbc.M114.595926 CrossRefPubMedPubMedCentral

88.

Wu JY, Feng L, Park HT, Havlioglu N, Wen L, Tang H, Bacon KB, Jiang Zh Z, Zhang Xc X, Rao Y (2001) The neuronal repellent slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 410:948–952. https://doi.org/10.1038/35073616 CrossRefPubMedPubMedCentral

89.

Wyss-Coray T, Borrow P, Brooker MJ, Mucke L (1997) Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice. J Neuroimmunol 77:45–50CrossRefPubMed

90.

Yen K, Lee C, Mehta H, Cohen P (2013) The emerging role of the mitochondrial-derived peptide humanin in stress resistance. J Mol Endocrinol 50:R11–R19. https://doi.org/10.1530/JME-12-0203 CrossRefPubMedPubMedCentral

91.

Yin X, Fang S, Wang M, Wang Q, Fang R, Chen J (2016) EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway. Oncotarget 7:47938–47953. https://doi.org/10.18632/oncotarget.10296 CrossRefPubMedPubMedCentral

92.

Zeis T, Howell OW, Reynolds R, Schaeren-Wiemers N (2018) Molecular pathology of multiple sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesis. Exp Neurol 305:76–88. https://doi.org/10.1016/j.expneurol.2018.03.012 CrossRefPubMed

Title: Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis
Authors: Maria L. Elkjaer
Tobias Frisch
Richard Reynolds
Tim Kacprowski
Mark Burton
Torben A. Kruse
Mads Thomassen
Jan Baumbach
Zsolt Illes
Publication date: 01-12-2019
Publisher: BioMed Central
Keyword: Multiple Sclerosis
Published in: Acta Neuropathologica Communications / Issue 1/2019
Electronic ISSN: 2051-5960
DOI: https://doi.org/10.1186/s40478-019-0855-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Brain tumor with an ATXN1-NUTM1 fusion gene expands the histologic spectrum of NUTM1-rearranged neoplasia

High-throughput microscopy exposes a pharmacological window in which dual leucine zipper kinase inhibition preserves neuronal network connectivity

Pediatric methylation class HGNET-MN1: unresolved issues with terminology and grading

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Transcriptome analysis of normal-appearing white matter reveals cortisol- and disease-associated gene expression profiles in multiple sclerosis

Targeting the β2-integrin LFA-1, reduces adverse neuroimmune actions in neuropathic susceptibility caused by prenatal alcohol exposure